The clinical trials on this list are studying Hydroxychloroquine. NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. Hydroxychloroquine brand name philippines Plaquenil and coughing Dermatomyositis rash and plaquenil Hydroxychloroquine patient reviews Pancreatic carcinoma is found among people who take Hydroxychloroquine sulfate, especially for people who are male, 50-59 old, have been taking the drug for 6 - 12 months, also take medication Methotrexate, Hydroxychloroquine is a quinoline medicine used to treat or prevent malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. Drugs used in chemotherapy, such as hydroxychloroquine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving trametinib together with hydroxychloroquine may work better in treating patients with pancreatic cancer. Talk to your doctor for help in deciding if one is right for you. You may want to think about taking part in a clinical trial. Hydroxychloroquine pancreatic cancer Phase II and Pharmacodynamic Study of Autophagy. - PubMed Central PMC, Hydroxychloroquine Uses, Dosage & Side Effects - Chloroquine breast cancerPlaquenil leg crampsHydroxychloroquine and yellow sweat stainsHow does plaquenil treat sjogrenIs plaquenil a tnf Mar 14, 2012 When scientists administered hydroxychloroquine, an anti-malarial drug, together with known cancer drugs, they found it stopped the growth of cancerous tumors in two-thirds of the patients. Scientists know that human cancer cells grow by getting energy from adjacent tumors, where cells have begun to self-destruct. Researches Say Hydroxychloroquine Can Help Treat Cancer.. Trametinib and Hydroxychloroquine in Treating Patients.. Phase II and pharmacodynamic study of autophagy inhibition.. Hydroxychloroquine is a substance that decreases immune responses in the body. Palbociclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Estrogen can cause the growth of breast cancer cells. Drugs, such as letrozole, may lessen the amount of estrogen made by the body. The primary goal of the research study is to determine whether treating pancreatic cancer patients with hydroxychloroquine in combination with gemcitabine before surgery is safe. The secondary goal is to determine if this new treatment regimen can effectively treat pancreatic cancer. Hydroxychloroquine is approved for the treatment of non-cancerous illnesses such as rheumatoid arthritis and systemic lupus erythematous. Researchers in the laboratory have tested tumors from patients with pancreatic cancer and have discovered that they have certain pathways inside the cells that promote growth and survival of the tumor.